Work

In vitro evidence supporting the use of exogenous IL-2 support for allogeneic UCART22 cells to treat heavily pretreated R/R B-ALL patients

Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417008347
Cites:
Cited by:
Related to: